Trials / Withdrawn
WithdrawnNCT01547325
Study of NanoDOX Hydrogel vs Placebo for Dehisced Surgical Wounds
Double-Blind, Single-Site, Pilot Study of NanoDOX Hydrogel Versus Placebo Hydrogel for Dehisced Surgical Wounds.
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- NanoSHIFT LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effects of NanoDOX Hydrogel versus Placebo Hydrogel on Dehisced Surgical Wounds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NanoDOX 1% doxycycline monohydrate Hydrogel | 1% doxycycline monohydrate hydrogel |
| DRUG | placebo hydrogel | placebo hydrogel |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2012-03-07
- Last updated
- 2017-03-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01547325. Inclusion in this directory is not an endorsement.